| API SYNTHESIS AND
MANUFACTURING |
Cynthia A. Challener
FDA looks to achieve near-record level of new drug approvals following slowdown in 2016. read more
| FORMULATION |
Adeline Siew, PhD
Abuse-deterrent opioid formulations generally fall into two categories: the first is based on a physiochemical abuse-deterrent approach and the second combines the opioid with an antagonist.
read more
| FLUID HANDLING |
Gregg Johnson
Proper selection and installation optimizes fluid system performance.
read more
| INTERNET OF THINGS |
Jennifer Markarian
The Industrial Internet of Things can be used in the bio/pharmaceutical industry to monitor equipment health, optimize processes, and enable modular facilities. read more
| PEER-REVIEWED RESEARCH |
Fasheng Li, Brad Evans, Fangfang Liu, Jingnan Zhang, Ke Wang, Aili Cheng
A new algorithm uses a statistical approach to critical process parameter assessment, allowing for faster and less subjective critical process parameter quantification, visualization, and documentation.
read more
| QUALITY |
Susan Haigney
Process validation is an extension of biologics development processes.
read more
| ELEMENTAL IMPURITIES |
Guy Bouvier, Amandine Gras, Jean-Guy Boiteau, Anne-Pascale Luzy, Jean-Pierre Etchegaray
The authors offer recommendations for permissible daily exposures and concentration limits of elemental impurities for dermal drug products.
read more
| PACKAGING |
Hallie Forcinio
Closures that protect solid-dosage drugs and the capping equipment that applies them have new product-protecting features.
read more
| PHAMACEUTICAL SERIALIZATION |
Agnes Shanley
Everyone may not be ready for the deadline, but open standards based on GAMP and GS1 will soon be released; more companies are also leveraging what they've learned from serialization to improve overall efficiency.
read more
| ASK THE EXPERT |
Siegfried Schmitt
Enterprise-wide processes, procedures, and systems are the keys to data integrity and peace of mind, according to Siegfried Schmitt, PhD, principal consultant at PAREXEL.
read more
| FROM THE EDITOR |
Rita C. Peters
Bio/pharma professionals manage expectations amid industry uncertainty.
read more
|